Ritleng AS - Search Results

Year	Number of Results
2008	1
2010	1
2011	1
2012	3
2013	1
2014	2
2015	7
2016	2
2017	5
2018	3
2019	3
2020	4
2021	4
2022	1
2023	3
2024	1

1

Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study.

Perfezou P, Hall N, Duthe JC, Abdi B, Seang S, Arvieux C, Lamaury I, Menard A, Marcelin AG, Katlama C, Palich R; Dat’AIDS study group. Perfezou P, et al. J Antimicrob Chemother. 2023 Aug 2;78(8):1929-1933. doi: 10.1093/jac/dkad185. J Antimicrob Chemother. 2023. PMID: 37303236 Free article.

2

Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.

Gantner P, Cuzin L, Allavena C, Cabie A, Pugliese P, Valantin MA, Bani-Sadr F, Joly V, Ferry T, Poizot-Martin I, Garraffo R, Peytavin G, Fafi-Kremer S, Rey D; Dat'AIDS study group. Gantner P, et al. HIV Med. 2017 Oct;18(9):704-708. doi: 10.1111/hiv.12506. Epub 2017 Apr 26. HIV Med. 2017. PMID: 28444816 Free article. No abstract available.

3

Drastic Reduction in Time to Controlled Viral Load in People With Human Immunodeficiency Virus in France, 2009-2019: A Longitudinal Cohort Study.

Cuzin L, Morisot A, Allavena C, Lert F, Pugliese P; Dat’AIDS Study Group. Cuzin L, et al. Clin Infect Dis. 2024 Jan 25;78(1):111-117. doi: 10.1093/cid/ciad530. Clin Infect Dis. 2024. PMID: 37665056

4

Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH).

Barré T, Zucman D, Marcellin F, Ramier C, Protopopescu C, Tardieu R, Ory K, Salmon-Céron D, Carrieri P; ANRS CO13 HEPAVIH Study Group. Barré T, et al. J Viral Hepat. 2023 Nov;30(11):897-900. doi: 10.1111/jvh.13865. Epub 2023 Jun 26. J Viral Hepat. 2023. PMID: 37357886 No abstract available.

5

Low-level viral loads and virological failure in the integrase strand transfer era.

Cuzin L, Flandre P, Allavena C, Palich R, Duvivier C, Becker A, Laroche H, Pugliese P, Cabie A; Dat’AIDS Study Group. Cuzin L, et al. J Antimicrob Chemother. 2023 Apr 3;78(4):1111-1116. doi: 10.1093/jac/dkad056. J Antimicrob Chemother. 2023. PMID: 36879512

6

Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.

Potard V, Reynes J, Ferry T, Aubin C, Finkielsztejn L, Yazdanpanah Y, Costagliola D; FHDH ANRS CO4. Potard V, et al. PLoS One. 2015 Dec 29;10(12):e0144746. doi: 10.1371/journal.pone.0144746. eCollection 2015. PLoS One. 2015. PMID: 26714012 Free PMC article.

7

No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.

Lajaunie R, Cuzin L, Palich R, Makinson A, Bani-Sadr F, Duvivier C, Arvieux C, Rey D, Poizot-Martin I, Delpierre C, Delobel P, Martin-Blondel G; And The Dat’AIDS study group. Lajaunie R, et al. HIV Med. 2022 Mar;23(3):301-306. doi: 10.1111/hiv.13168. Epub 2021 Oct 19. HIV Med. 2022. PMID: 34668293 Free article.

8

Ageing with HIV: do comorbidities and polymedication drive treatment optimization?

Cuzin L, Katlama C, Cotte L, Pugliese P, Cheret A, Bernaud C, Rey D, Poizot-Martin I, Chirouze C, Bani-Sadr F, Cabié A; Dat'AIDS Study Group. Cuzin L, et al. HIV Med. 2017 Jul;18(6):395-401. doi: 10.1111/hiv.12441. Epub 2016 Oct 7. HIV Med. 2017. PMID: 28858437 Free article.

9

Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018.

Cotte L, Hocqueloux L, Lefebvre M, Pradat P, Bani-Sadr F, Huleux T, Poizot-Martin I, Pugliese P, Rey D, Cabié A; Dat’AIDS Study Group. Cotte L, et al. Clin Infect Dis. 2021 Nov 2;73(9):e3266-e3274. doi: 10.1093/cid/ciaa1940. Clin Infect Dis. 2021. PMID: 33400777

10

Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting.

Deschanvres C, Reynes J, Lamaury I, Rey D, Palich R, Bani-Sadr F, Robineau O, Duvivier C, Hocqueloux L, Cuzin L, Joly V, Raffi F, Cabie A, Allavena C; Dat’AIDS Study Group. Deschanvres C, et al. J Antimicrob Chemother. 2021 Dec 24;77(1):196-204. doi: 10.1093/jac/dkab367. J Antimicrob Chemother. 2021. PMID: 34651192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year